Profile data is unavailable for this security.
About the company
CHINA CHEMICAL & PHARMACEUTICAL CO., LTD. is a Taiwan-based company principally engaged in the manufacture and sales of pharmaceuticals. The products of the Company include pharmaceuticals for human, animal drugs, medical devices, daily products and nutritious food products. Pharmaceuticals for human include prescription drugs and patented medicines, among others. Medical equipment includes nursing liquid for contact lens, sphygmomanometers and manmade joints. Animal drugs include feedstuff additives and healthcare products for animals, among others. Daily products include toothpastes, shower liquid, facial masks and mouth rinses, among others. The Company operates businesses in Taiwan and Mainland China.
- Revenue in TWD (TTM)8.76bn
- Net income in TWD327.98m
- Incorporated1952
- Employees1.40k
- LocationChina Chemical & Pharmaceutical Co LtdNo. 23Hsiang Yang Road, Jhongjheng DistrictTAIPEI 100TaiwanTWN
- Phone+886 223124200
- Fax+886 223615143
- Websitehttp://www.ccpc.com.tw/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Phytohealth Corp | 162.12m | -67.65m | 3.88bn | 84.00 | -- | 1.96 | -- | 23.95 | -0.3406 | -0.3406 | 0.8162 | 9.96 | 0.0687 | 0.628 | 5.49 | -- | -4.20 | -5.66 | -5.04 | -7.31 | 39.43 | 47.70 | -61.09 | -92.91 | 30.49 | -- | 0.0115 | -- | 19.95 | 8.62 | 40.67 | -- | -39.46 | -- |
Chunghwa Chemical Synthsis&Biotech CoLtd | 1.57bn | 126.22m | 3.98bn | 243.00 | 31.63 | 1.18 | 12.53 | 2.53 | 1.62 | 1.62 | 20.19 | 43.58 | 0.3072 | 0.9703 | 4.27 | -- | 2.47 | 9.03 | 2.95 | 10.56 | 33.44 | 43.26 | 8.03 | 20.15 | 0.5999 | -- | 0.2823 | 24.83 | -1.45 | 15.40 | -43.14 | 2.49 | 36.95 | -7.79 |
Nang Kuang Pharmaceutical Co Ltd | 2.11bn | 159.13m | 4.70bn | 552.00 | 29.54 | 2.11 | 13.75 | 2.23 | 1.57 | 1.57 | 20.83 | 22.08 | 0.5823 | 1.83 | 7.93 | -- | 4.40 | 6.75 | 6.29 | 9.64 | 34.36 | 34.77 | 7.56 | 12.22 | 0.6212 | 23.03 | 0.117 | 82.74 | 10.81 | 6.92 | -43.63 | 14.41 | 19.51 | 10.76 |
Sinphar Pharmaceutical Co Ltd | 2.97bn | 405.43m | 6.26bn | 984.00 | 15.47 | 1.94 | 10.07 | 2.11 | 2.41 | 2.41 | 17.68 | 19.22 | 0.4824 | 2.25 | 5.70 | -- | 6.35 | -0.0147 | 8.35 | -0.0203 | 37.81 | 37.49 | 13.17 | -0.0344 | 1.52 | 33.73 | 0.3542 | 79.70 | 3.72 | 5.98 | 67.01 | 111.88 | 3.31 | 58.49 |
China Chemical & Pharmaceutical Co Ltd | 8.76bn | 327.98m | 6.65bn | 1.40k | 20.28 | 0.8889 | 10.11 | 0.7586 | 1.10 | 1.10 | 29.36 | 25.09 | 0.6814 | 2.21 | 5.55 | -- | 2.57 | 3.69 | 3.55 | 4.96 | 36.61 | 36.56 | 3.77 | 5.50 | 0.8324 | -- | 0.3172 | 52.77 | 1.40 | 2.50 | -32.51 | -2.72 | 3.57 | -8.97 |
Panion & BF Biotech Inc | 1.97bn | 98.39m | 8.33bn | 321.00 | 84.65 | 4.55 | 30.89 | 4.22 | 1.15 | 1.15 | 23.00 | 21.36 | 0.6337 | 1.66 | 10.01 | -- | 3.16 | 4.08 | 4.77 | 5.63 | 52.54 | 52.37 | 4.99 | 5.93 | 0.7978 | 6.41 | 0.2726 | 111.06 | -21.54 | 5.96 | -57.65 | -13.47 | 35.39 | -3.23 |
Holder | Shares | % Held |
---|---|---|
The Vanguard Group, Inc.as of 04 Jul 2024 | 9.60m | 3.22% |
Dimensional Fund Advisors LPas of 04 Jul 2024 | 5.00m | 1.68% |
SSgA Funds Management, Inc.as of 03 Jul 2024 | 4.93m | 1.65% |
Norges Bank Investment Managementas of 31 Dec 2023 | 2.63m | 0.88% |
Mellon Investments Corp.as of 03 Jul 2024 | 544.00k | 0.18% |
American Century Investment Management, Inc.as of 03 Jul 2024 | 362.00k | 0.12% |
Dimensional Fund Advisors Ltd.as of 31 May 2024 | 304.45k | 0.10% |
DFA Australia Ltd.as of 31 May 2024 | 132.72k | 0.05% |
Vanguard Global Advisers LLCas of 30 Jun 2024 | 28.00k | 0.01% |
Irish Life Investment Managers Ltd.as of 04 Jul 2024 | 19.23k | 0.01% |